Edward A. Ogunro
Director/Board Member at MPN Research Foundation
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bobby Reddy | M | - |
Prenosis, Inc.
 Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | - |
| Mary Gardner | F | - |
DelNova, Inc.
 DelNova, Inc. Pharmaceuticals: MajorHealth Technology DelNova, Inc. engages in the development of therapeutics. Its lead clinical candidate is ReViVox?, a patent-pending product for the rescue of complications caused by off-target muscle paralysis following aesthetic and medical neurotoxin therapies. The company was founded by Mary Gardner in 2016 and is headquartered in Highland, IL. | 8 years |
| Andrea Giubboni | M | - | 3 years | |
| Daniel Bradbury | M | 62 |
DelNova, Inc.
DelNova, Inc. Pharmaceuticals: MajorHealth Technology DelNova, Inc. engages in the development of therapeutics. Its lead clinical candidate is ReViVox?, a patent-pending product for the rescue of complications caused by off-target muscle paralysis following aesthetic and medical neurotoxin therapies. The company was founded by Mary Gardner in 2016 and is headquartered in Highland, IL. | - |
| Sean Murphy | M | 71 |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | 2 years |
| Mark T. Wagner | M | 67 |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | 2 years |
| Julia M. Peev | F | - |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | 2 years |
| Reid Sadler | M | - | 10 years | |
| Julia Monfrini Peev | F | - |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | 3 years |
| John Hoffarth | M | - | 3 years | |
| Jim Zhao | M | - |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Harriss T. Currie | M | 62 | 23 years | |
| Thomas W. Erickson | M | 73 | 19 years | |
| Homi Shamir | M | 70 | - | |
| David Ellison | M | 62 |
Applied NeuroSolutions, Inc.
 Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | 15 years |
| Richard W. Rew | M | 56 | 6 years | |
| Patrick Balthrop | M | 67 | 10 years | |
| Ellen R. Hoffing | F | 66 |
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | 5 years |
| Christopher Begley | M | 71 | 8 years | |
| John Staley | M | 82 | 11 years | |
| GOAD FRED | M | 79 | 19 years | |
| Kever Jim D | M | 71 | 25 years | |
| Robert J. Cresci | M | 80 | 23 years | |
| Connie R. Curran | M | 76 | 10 years | |
| Craig S. Taylor | M | - |
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | 1 years |
| Timothy Dehne | M | 58 | 4 years | |
| Russell W. Bradley | M | 60 | 11 years | |
| Dijuana K. Lewis | F | 64 | 2 years | |
| Kenneth Samet | M | 65 | 3 years | |
| Stephen Eck | M | 69 | 5 years | |
| Roger W. Hale | M | 80 | 9 years | |
| Kay Williams | F | - | - | |
| Kevin McNamara | M | 68 | 14 years | |
| Mark F. Wheeler | M | 74 | 9 years | |
| Irving Bailey | M | 83 | - | |
| David S. Reiter | M | 57 | 12 years | |
| Jacque Sokolov | M | 69 | 11 years | |
| G. Loewenbaum | M | 79 | 25 years | |
| Jay B. Johnston | M | 77 | 12 years | |
| Gérard Vaillant | M | 82 | 7 years | |
| Jeremy K. Bridge-Cook | M | 55 | 9 years | |
| Brian Joseph Smith | M | 72 | - | |
| Kendel B. Martin | F | - | 14 years | |
| Mike Nolan | M | - | - | |
| Marc Hoffman | M | 63 | 2 years | |
| Randall J Myers | M | - | - | |
| Stefan J. Cross | M | 51 | 5 years | |
| David Bourne | M | - | 6 years | |
| Andrew Robbins | M | 48 | 5 years | |
| John Gerace | M | 60 | - | |
| J. Stark Thompson | M | 82 | 4 years | |
| Brian O’Leary | M | - |
Feinberg School of Medicine
| 3 years |
| Robin A. Atlas | M | - |
Feinberg School of Medicine
| 3 years |
| Tadd Lazarus | M | - | - | |
| Piergiorgio Pedron | M | 53 | - | |
| Geraldine Storton | F | - | 9 years | |
| Todd C. Bennett | M | 54 | 9 years | |
| Eric S. Shapiro | M | 60 | 6 years | |
| Thomas G. Moore | M | 72 | 4 years | |
| Joern Mosner | M | - | 4 years | |
| Carla Stanaford | F | - | - | |
| David Griss | M | - | 6 years | |
| Kent Pflederer | M | 53 | 3 years | |
| Ronald D. Dunn | M | - | - | |
| Alan L. Heller | M | 70 |
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | 4 years |
| Judith C. Pelham | F | 78 | 1 years | |
| William L. Weiss | M | - | - | |
| Gary C. Parks | M | 74 |
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | 3 years |
| David C. U'Prichard | M | 75 |
Feinberg School of Medicine
| 5 years |
| Richard Hoffman | M | 57 | - | |
| David C. Tiemeier | M | 77 |
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | 4 years |
| John Arnott | M | 63 | - | |
| Robert S. Vaters | M | 63 |
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | 3 years |
| Jay Langner | M | 95 |
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | 3 years |
| Scott Johnson | M | - | 15 years | |
| David A. Jones | M | 92 | 3 years | |
| Thomas E. Werner | M | 66 | - | |
| Ron Squarer | M | 57 | 5 years | |
| Tom Moutvic | M | 62 | 22 years | |
| Lauren Flanagan | F | - | 8 years | |
| Ronald A. Matricaria | M | 81 | 4 years | |
| Michael F. Pintek | M | 55 | - | |
| Timothy Oldham | M | - | 5 years | |
| Cole Tims | M | - | 4 years | |
| Nancy M. Fairchild | F | 70 | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 85 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Edward A. Ogunro
- Personal Network
